Abstract
Recombinant urokinase has been refolded and purified from Escherichia coli in both its high and low molecular weight forms. The low molecular weight form of the protein has been characterized by specific activity, amino acid composition, amino terminal analysis, carboxy terminal analysis, tryptic mapping, antibody titrations, and chromatographic behavior. The high molecular weight form has been characterized by specific activity and chromatographic behavior. With the exception of the lack of carbohydrate attached to Asn 302, the recombinant urokinase is almost identical to natural urokinase in every way tested. The results indicate that the urokinase can be properly folded from E. coli and that the carbohydrate attached to natural urokinase does not play a role in the catalytic activity of the enzyme.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bernik, M.B. and Kwaan, H.C. 1967. Origin of fibrinolytic activity in cultures of the human kidney. J. Lab. Clin. Med. 70: 650–661.
Bernik, M.B. and Oller, E.P. 1973. Increased plasminogen activator (urokinase) in tissue culture after fibrin deposition. J. Clin. Invest., 52: 823–834.
Booyse, F.M., Osikowicz, G., Feder, S. and Sheinbuks, J. 1984. Isolation and characterization of a urokinase-type plasminogen activator (Mr=54,000) from cultured human endothelial cells indistinguishable from urinary urokinase. J. Biol. Chem. 259: 7198–7205.
White, W.F., Barlow, G.H. and Mozen, M.M. 1966. The isolation and characterization of plasminogen activators (urokinase) from human urine. Biochemistry 5: 2160–2169.
Gunzler, W.A., Steffens, G.J., Otting, F., Kim, S.A., Frankus, E. and Flohe, L. 1982. The primary structure of high molecular mass urokinase from human urine: The complete amino acid sequence of the A chain. Hoppe-Seyler's Z. Physiol. Chem. Bd. 363: 1155–1165.
Steffens, G.J., Gunzler, W.A., Otting, F., Frankus, E. and Flohe, L. 1982. The complete amino acid sequence of low molecular mass urokinase from human urine. Hoppe-Seyler's Z. Physiol. Chem. Bd. 363: 1043–1058.
Holmes, W.E., Pennica, D., Blaber, M., Gunzler, W.A., Steffens, G.J. and Heyneker, H.L. 1985. Cloning and expression of human urokinase type plasminogen activator in Escherichia coli. Bio/Technology 3: 923–929.
DeBoer, H.A., Comstock, L.J. and Vasser, M. 1983. The tac promotor: A functional hybrid derived from the trp and lac promoters. Proc. Natl. Acad. Sci. USA 80: 21–25.
Ahmed, A.K., Schaffer, S.W. and Wetlaufer, D.B. 1975. Nonenzymatic reactivation of reduced bovine pancreatic ribonuclease by air oxidation and by glutathione oxidoreduction buffers. J. Biol. Chem. 250: 8477–8482.
Granelli-Piperno, A. and Reich, E. 1978. A study of proteases and protease-inhibitor complexes in biological fluids. J. Exp. Med. 148: 223–234.
deHaen, C., Neurath, H. and Teller, D.C. 1975. The phylogeny of trypsin-related serine proteases and their zymogens. New methods for the investigation of distant evolutionary relationships. J. Mol. Biol. 92: 225–259.
Steffens, G.J., Gunzler, W.A., Henninger, W., Hennies, H.H., Kim, S.M.A., Otting, F., Frankus, E., Flohe, L., Blaber, M. and Winkler, M. 1984. Molecular characterization of human urokinase produced in bacteria as compared to urokinase obtained from human urine. 7th Internat. Congr. on Fibrinolysis (Venice, Italy) Haemostasis Abs. No. 105.
Morehead, H., McKay, P. and Wetzel, R. 1982. High-performance liquid chromatography analysis in the synthesis, characterization, and reactions of neoglycopeptides. Anal. Biochem. 126: 29–36.
Varadi, A. and Patthy, L. 1981. Kringle 5 of human plasminogen carries a benzamidine-binding site. Biochem Biophys. Res. Commun. 103: 97–102.
Sumi, H. and Robbins, K.C. 1983. A functionally active heavy chain derived from human high molecular weight urokinase. J. Biol. Chem. 258: 8014–8019.
Linscott, W.D. 1963. Contamination of commercial rabbit albumin preparations by bovine albumin. Science 142: 1170–1172.
Minden, P. and Farr, R.S. 1978. Ammonium sulphate method to measure antigen-binding capacity, chapter 13. In: Handbook of Experimental Immunology, Third Edition. Weir, D. M. (ed.), Black-well Scientific Publications, Oxford, U.K.
Lidd, D. and Farr, R.S. 1963. Similarities between antigens derived from ragweed pollen and from other botanical sources. J. Allerg. 34: 48–62.
Sottrup-Jensen, L., Claeys, H., Zajdel, M., Petersen, T.E. and Magnusson, S. 1978. The primary structure of human plasminogen: Isolation of two lysine-binding fragments and one “mini” plasminogen (M.W.=38,000) by elastase-catalyzed specific limited proteolysis. Progress in Chemical Fibrinolysis and Thrombolysis 3: 191–209.
Rijken, D.C. and Collen, D. 1981. Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture. J. Biol. Chem. 256: 7035–7041.
Strickland, T.W. and Pierce, J.G. 1985. Effect of carbohydrate on the folding of the α-subunit of the bovine glycoprotein hormones. J. Cell Biochem. Supplement 9B, 124, Abst. No. 0724.
Collen, D., DeCock, F. and Lijnen, H.R. 1984. Biological and thrombolytic properties of proenzyme and active forms of human urokinase II. Turnover of natural and recombinant urokinase in rabbits and squirrel monkeys. Thromb. Haemostas. 52: 24–26.
Collen, D., Stassen, J.M., Blaber, M., Winkler, M. and Verstraete, M. 1984. Biological and thrombolytic properties of proenzyme and active forms of human urokinase. III. Thrombolytic properties of natural and recombinant urokinase in rabbits with experimental jugular vein thrombosis. Thromb. Haemostas. 52: 27–30.
Holmberg, L., Bladh, B. and Astedt, B. 1976. Purification of urokinase by affinity chromatography. Biochim. Biophys. Acta 445: 215–222.
Laemmli, U.K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680–685.
Burnette, W.N. 1981. “Western Blotting”: Electrophoretic transfer of proteins from sodium dodecyl sulfate polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal. Biochem. 112: 195–203.
Ploug, J. and Kjeldgaard, N.O. 1957. Urokinase: An activator of plasminogen from human urine. I. Isolation and properties. Biochim. Biophys. Acta 24: 278–282.
Hayashi, S. and Yamada, K. 1981. Assay of urokinase activity in plasma with a chromogenic substrate. Thrombosis Research, 22: 573–578.
Shimada, H., Mori, T., Takada, A., Takada, Y., Noda, Y., Takai, I., Kohda, H. and Nishimura, T. 1981. Use of chromogenic substrate S-2251 for determination of plasminogen activator in rat ovaries. Thromb. Haemostas. 46: 507–510.
Rodriguez, H., Kohr, W.J. and Harkins, R.N. 1984. Design and Operation of a Completely Automated Beckman Microsequencer. Analytical Biochem., 140: 538–547.
Greenwood, F.C., Hunter, W.M. and Glover, J.S. 1963. The preparation of 131I-labelled human growth hormone of high specific radioactivity. Biochem. J. 89: 114–123.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Winkler, M., Blaber, M., Bennett, G. et al. Purification and Characterization of Recombinant Urokinase from Escherichia coli. Nat Biotechnol 3, 990–1000 (1985). https://doi.org/10.1038/nbt1185-990
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/nbt1185-990
This article is cited by
-
Expression, Purification, and Characterization of Scar Tissue Neovasculature Endothelial Cell-Targeted rhIL10 in Escherichia Coli
Applied Biochemistry and Biotechnology (2015)
-
Cloning and Expression of the Gene for Pro-urokinase in Escherichia coli
Bio/Technology (1985)